Josephine Ma

Hong Kong

Josephine Ma

News editor, China

Josephine Ma is China news editor and has covered China news for the Post for more than 20 years. As a correspondent in Beijing, she reported on everything from the 2003 Sars outbreak to the riots in Lhasa and the Beijing Olympics in 2008. She has been based in Hong Kong since 2009. She has a master’s degree in development studies from the London School of Economics and a bachelor’s degree in English language from the Chinese University of Hong Kong.

Show more

Latest from Josephine Ma

Explainer | What do the Sinovac coronavirus vaccine efficacy results mean?

The company and its Brazilian partner have released confusing numbers for the effectiveness of CoronaVac in clinical trials.

15 Jan 2021 - 6:40PM

The company and its Brazilian partner have released confusing numbers for the effectiveness of CoronaVac in clinical trials.

What do the Sinovac coronavirus vaccine efficacy results mean?
China’s Sinovac defends Brazil results but regulators to look hard at data

Chinese firm seeks to clarify Brazilian partner’s announcement that CoronaVac is 50 per cent effective.

14 Jan 2021 - 2:38PM

Chinese firm seeks to clarify Brazilian partner’s announcement that CoronaVac is 50 per cent effective.

China’s Sinovac defends Brazil results but regulators to look hard at data
Coronavirus: Scientists concerned by way data from Chinese drug firm Sinovac’s vaccine trials is coming out

The firm’s Brazilian partner has promised to disclose more information after it claimed the drug had a 78 per cent efficacy rate.

12 Jan 2021 - 11:14PM

The firm’s Brazilian partner has promised to disclose more information after it claimed the drug had a 78 per cent efficacy rate.

Coronavirus: Scientists concerned by way data from Chinese drug firm Sinovac’s vaccine trials is coming out
Coronavirus: how will the vaccine advances of 2020 alter the pandemic path in 2021?

The extreme lows brought by Covid-19 have sparked unprecedented speed in developing and approving vaccines and rolling them out.

13 Jan 2021 - 3:27PM

The extreme lows brought by Covid-19 have sparked unprecedented speed in developing and approving vaccines and rolling them out.

Coronavirus: how will the vaccine advances of 2020 alter the pandemic path in 2021?
Coronavirus: a Sinovac Biotech vaccine is seen as 78 per cent effective in Brazil

Announcement by Sao Paulo state government paves the way for emergency use approvals and roll-out in an array of countries and regions, including Hong Kong.

8 Jan 2021 - 5:29PM

Announcement by Sao Paulo state government paves the way for emergency use approvals and roll-out in an array of countries and regions, including Hong Kong.

Coronavirus: a Sinovac Biotech vaccine is seen as 78 per cent effective in Brazil
Coronavirus: China’s Sinovac shots readied for mass roll-out in Indonesia, Philippines and Thailand

Indonesian President Joko Widodo will be the first to get the jab when inoculations begin on January 13.

7 Jan 2021 - 11:01PM

Indonesian President Joko Widodo will be the first to get the jab when inoculations begin on January 13.

Coronavirus: China’s Sinovac shots readied for mass roll-out in Indonesia, Philippines and Thailand
Coronavirus: China says it can produce 1 billion doses of a Sinopharm vaccine this year

The Ministry of Industry and Information says there will be enough vaccine for mass inoculations domestically, including 100 million doses ahead of the Lunar New Year.

6 Jan 2021 - 9:45AM

The Ministry of Industry and Information says there will be enough vaccine for mass inoculations domestically, including 100 million doses ahead of the Lunar New Year.

Coronavirus: China says it can produce 1 billion doses of a Sinopharm vaccine this year
As I see it | Beijing may balk at ‘vaccine diplomacy’ term but beating Covid-19 is key to China’s outreach plan

State media rejects that China’s future vaccine aid is conditional while Beijing admits it is in a propaganda battle to reshape the pandemic narrative.

5 Jan 2021 - 10:13PM

State media rejects that China’s future vaccine aid is conditional while Beijing admits it is in a propaganda battle to reshape the pandemic narrative.

Beijing may balk at ‘vaccine diplomacy’ term but beating Covid-19 is key to China’s outreach plan
As I see it | Chinese authorities must try to dispel the confusion over coronavirus vaccines

Recent delays to the efficacy data for a drug made by Sinovac has only served to muddy the waters further.

27 Dec 2020 - 11:30PM

Recent delays to the efficacy data for a drug made by Sinovac has only served to muddy the waters further.

Chinese authorities must try to dispel the confusion over coronavirus vaccines
My Take | For China’s coronavirus vaccines, public trust is in the detailed data

The US drug regulator has broadcast advisory committee hearings live and put questions directly to pharmaceutical executives.

18 Dec 2020 - 11:06PM

The US drug regulator has broadcast advisory committee hearings live and put questions directly to pharmaceutical executives.

For China’s coronavirus vaccines, public trust is in the detailed data
Coronavirus: China to vaccinate 50 million people for Lunar New Year

Millions of people in high-priority groups expected to get the shots before the holiday travel season to prevent outbreaks.

17 Dec 2020 - 11:30PM

Millions of people in high-priority groups expected to get the shots before the holiday travel season to prevent outbreaks.

Coronavirus: China to vaccinate 50 million people for Lunar New Year
After the coronavirus research race, vaccine producers face new hurdles

Production challenges differ widely between the traditional vaccines developed in China and advanced mRNA products.

16 Dec 2020 - 10:14PM

Production challenges differ widely between the traditional vaccines developed in China and advanced mRNA products.

After the coronavirus research race, vaccine producers face new hurdles
UAE approves ‘86 per cent effective’ Chinese coronavirus vaccine

Review of Sinopharm’s interim analysis of phase three trials found ‘no serious safety concerns’, health ministry says.

10 Dec 2020 - 11:43AM

Review of Sinopharm’s interim analysis of phase three trials found ‘no serious safety concerns’, health ministry says.

UAE approves ‘86 per cent effective’ Chinese coronavirus vaccine
As I see it | Covid-19 vaccines are on the way. But making them compulsory will only backfire

Transparency is the best way to counter public mistrust and misinformation spread by anti-vaxxers.

9 Dec 2020 - 2:16PM

Transparency is the best way to counter public mistrust and misinformation spread by anti-vaxxers.

Covid-19 vaccines are on the way. But making them compulsory will only backfire
Covid vaccine reality: supply, anxiety, QR codes & 'Covid normal' travel
Covid-19 vaccines poised for approval in the West. But what about China?

Britain became the first country to approve a drug developed by Pfizer and BioNTech, with regulators in the US and Europe also considering applications.

10 Dec 2020 - 11:36AM

Britain became the first country to approve a drug developed by Pfizer and BioNTech, with regulators in the US and Europe also considering applications.

Covid-19 vaccines poised for approval in the West. But what about China?
China’s ‘bat woman’ virologist rules out Covid-19 virus in fresh tests on old cave samples

In an update to an earlier paper that spawned conspiracy theories, Shi Zhengli details how they found a bat virus ‘96 per cent similar’ to the pandemic coronavirus.

21 Nov 2020 - 9:09AM

In an update to an earlier paper that spawned conspiracy theories, Shi Zhengli details how they found a bat virus ‘96 per cent similar’ to the pandemic coronavirus.

China’s ‘bat woman’ virologist rules out Covid-19 virus in fresh tests on old cave samples
Coronavirus: 1 million Chinese injected with Sinopharm vaccine under emergency use scheme

‘There has not been a single case of a serious adverse event,’ chairman of state-owned company says.

10 Dec 2020 - 11:05AM

‘There has not been a single case of a serious adverse event,’ chairman of state-owned company says.

Coronavirus: 1 million Chinese injected with Sinopharm vaccine under emergency use scheme
Coronavirus: Pfizer and BioNtech to seek emergency US approval ‘within days’ after better-than-expected test results

The two companies say it achieved 95 per cent efficacy in final clinical trials and is equally effective for over-65s.

10 Dec 2020 - 11:19AM

The two companies say it achieved 95 per cent efficacy in final clinical trials and is equally effective for over-65s.

Coronavirus: Pfizer and BioNtech to seek emergency US approval ‘within days’ after better-than-expected test results
As I see it | Can World Health Organization’s coronavirus investigation really find the source of the outbreak?

Scientists will study its spread in Wuhan but the Chinese authorities may not give them access to the raw data from the city.

18 Nov 2020 - 7:23AM

Scientists will study its spread in Wuhan but the Chinese authorities may not give them access to the raw data from the city.

Can World Health Organization’s coronavirus investigation really find the source of the outbreak?
US-China tech war: who is the ‘virtuous’ man Xi Jinping says is a model for other businesspeople?

Learn from Zhang Jian, Xi says at a museum founded by the Qing dynasty entrepreneur.

13 Nov 2020 - 10:30PM

Learn from Zhang Jian, Xi says at a museum founded by the Qing dynasty entrepreneur.

US-China tech war: who is the ‘virtuous’ man Xi Jinping says is a model for other businesspeople?
As I see it | Science may be back when Biden is in but there’s no magic cure for coronavirus

Joe Biden has made the pandemic a priority by assembling a team of experts to tackle it.

10 Nov 2020 - 11:15PM

Joe Biden has made the pandemic a priority by assembling a team of experts to tackle it.

Science may be back when Biden is in but there’s no magic cure for coronavirus
China's Covid vaccines: mass inoculations begin, what the global Covax deal means
China vows to build ‘fully modern army’ by 2027 as Beijing policy meeting ends on defiant note

The four-day plenum in Beijing wraps up with a statement that says it has entered a period of ‘strategic opportunity’ for development.

30 Oct 2020 - 9:47PM

The four-day plenum in Beijing wraps up with a statement that says it has entered a period of ‘strategic opportunity’ for development.

China vows to build ‘fully modern army’ by 2027 as Beijing policy meeting ends on defiant note
Chinese Communist Party wraps up top policy meeting by outlining plans for nation to become greater power

Discussions at the party’s most important meeting of the year expected to centre on ambitious plans for greater power.

30 Oct 2020 - 11:36AM

Discussions at the party’s most important meeting of the year expected to centre on ambitious plans for greater power.

Chinese Communist Party wraps up top policy meeting by outlining plans for nation to become greater power
Opinion | Time for China to align with global practice in counting coronavirus cases

Since February, China’s coronavirus tally of ‘confirmed’ cases has not included positive patients who are asymptomatic or presymptomatic.

27 Oct 2020 - 10:32PM

Since February, China’s coronavirus tally of ‘confirmed’ cases has not included positive patients who are asymptomatic or presymptomatic.

Time for China to align with global practice in counting  coronavirus cases
Can China become a leading producer of Covid-19 vaccines?

Coronavirus pandemic and the rise of its big players could be game-changer for Chinese vaccine industry, experts say.

28 Oct 2020 - 6:05PM

Coronavirus pandemic and the rise of its big players could be game-changer for Chinese vaccine industry, experts say.

Can China become a leading producer of Covid-19 vaccines?
World Health Organization defends Covid-19 drug study after remdesivir maker Gilead questions methodology

Research has raised questions about whether the antiviral, which was one of the drugs given to Donald Trump, is any use in treating the disease

18 Oct 2020 - 9:00AM

Research has raised questions about whether the antiviral, which was one of the drugs given to Donald Trump, is any use in treating the disease

World Health Organization defends Covid-19 drug study after remdesivir maker Gilead questions methodology
Xi Jinping calls on Shenzhen to create ‘another miracle’ in next stage of reform

Chinese president tasks city with becoming world-class innovation powerhouse and says it will be given more autonomy to make reforms.

15 Oct 2020 - 1:05AM

Chinese president tasks city with becoming world-class innovation powerhouse and says it will be given more autonomy to make reforms.

Xi Jinping calls on Shenzhen to create ‘another miracle’ in next stage of reform
As I see it | Donald Trump’s treatment reminds us to hedge bets on Covid-19 research

High costs may limit accessibility of monoclonal antibody treatment, and uncertainties have been raised by pharma firm Eli Lilly’s suspension of its trial.

14 Oct 2020 - 4:01PM

High costs may limit accessibility of monoclonal antibody treatment, and uncertainties have been raised by pharma firm Eli Lilly’s suspension of its trial.

Donald Trump’s treatment reminds us to hedge bets on Covid-19 research